WO2008016660A3 - Imidazoacridine compounds for treating leukemias - Google Patents
Imidazoacridine compounds for treating leukemias Download PDFInfo
- Publication number
- WO2008016660A3 WO2008016660A3 PCT/US2007/017222 US2007017222W WO2008016660A3 WO 2008016660 A3 WO2008016660 A3 WO 2008016660A3 US 2007017222 W US2007017222 W US 2007017222W WO 2008016660 A3 WO2008016660 A3 WO 2008016660A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- imidazoacridine
- compounds
- treating leukemias
- treating
- leukemias
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
A method of treating a patient suffering from certain types of leukemia, comprising administering to said patient a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof. Definitions for the variables are provided therein.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83502806P | 2006-08-02 | 2006-08-02 | |
US83506406P | 2006-08-02 | 2006-08-02 | |
US60/835,064 | 2006-08-02 | ||
US60/835,028 | 2006-08-02 | ||
US87385006P | 2006-12-08 | 2006-12-08 | |
US60/873,850 | 2006-12-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008016660A2 WO2008016660A2 (en) | 2008-02-07 |
WO2008016660A3 true WO2008016660A3 (en) | 2008-04-24 |
Family
ID=38792006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/017222 WO2008016660A2 (en) | 2006-08-02 | 2007-08-02 | Imidazoacridine compounds for treating leukemias |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008016660A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2428508T3 (en) * | 2009-05-08 | 2016-05-31 | Astellas Pharma Inc | Diamino heterocyclic carboxamide compound |
CN116425828A (en) * | 2023-04-03 | 2023-07-14 | 浙江大学 | Small molecule compound for degrading HDAC7 protein, and preparation and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0502668A1 (en) * | 1991-03-05 | 1992-09-09 | Btg International Limited | Imidazoacridines and their antineoplastic use |
WO2001066545A2 (en) * | 2000-03-07 | 2001-09-13 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 1,8-NAPHTHALIMIDE IMIDAZO[4,5,1-de]ACRIDONES WITH ANTI-TUMOR ACTIVITY |
WO2007016338A2 (en) * | 2005-07-29 | 2007-02-08 | Goverment Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Use of chk2 kinase inhibitors for cancer treatment |
WO2007092436A2 (en) * | 2006-02-08 | 2007-08-16 | Xanthus Pharmaceuticals, Inc. | Compounds for treating inflammatory disorders, demyelinating disorders and cancers |
-
2007
- 2007-08-02 WO PCT/US2007/017222 patent/WO2008016660A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0502668A1 (en) * | 1991-03-05 | 1992-09-09 | Btg International Limited | Imidazoacridines and their antineoplastic use |
WO2001066545A2 (en) * | 2000-03-07 | 2001-09-13 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 1,8-NAPHTHALIMIDE IMIDAZO[4,5,1-de]ACRIDONES WITH ANTI-TUMOR ACTIVITY |
WO2007016338A2 (en) * | 2005-07-29 | 2007-02-08 | Goverment Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Use of chk2 kinase inhibitors for cancer treatment |
WO2007092436A2 (en) * | 2006-02-08 | 2007-08-16 | Xanthus Pharmaceuticals, Inc. | Compounds for treating inflammatory disorders, demyelinating disorders and cancers |
Non-Patent Citations (6)
Title |
---|
AUGUSTIN E ET AL: "Imidazoacridinones arrest cell-cycle progression in the G2 phase of L1210 cells", CANCER CHEMOTHERAPY AND PHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 38, no. 1, 1996, pages 39 - 44, XP008085895, ISSN: 0344-5704 * |
CHOLODY WIESLAW M ET AL: "Structure-activity relationship for antineoplastic imidazoacridinones: Synthesis and antileukemic activity in vivo", JOURNAL OF MEDICINAL CHEMISTRY, vol. 39, no. 5, 1996, pages 1028 - 1032, XP002468996, ISSN: 0022-2623 * |
CHOLODY, WIESLAW M. ET AL: "Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias", JOURNAL OF MEDICINAL CHEMISTRY , 35(2), 378-82 CODEN: JMCMAR; ISSN: 0022-2623, 1992, XP002468995 * |
MAZERSKA Z ET AL: "QSAR of acridines, III. Structure-activity relationship for antitumor imidazoacridinones and intercorrelations between in vivo and in vitro tests", ANTI-CANCER DRUG DESIGN, BASINGSTOKE, GB, vol. 11, no. 1, 1996, pages 73 - 88, XP008085898, ISSN: 0266-9536 * |
MAZERSKA ZOFIA ET AL: "C-1311: Atineoplastic", DRUGS OF THE FUTURE, BARCELONA, ES, vol. 23, no. 7, July 1998 (1998-07-01), pages 702 - 706, XP002459524, ISSN: 0377-8282 * |
MYDOANH CHAU ET AL: "Imidazoacridinones are bifunctional targeting agents active in leukemia cells", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, vol. 108, no. 11, PART 1, November 2006 (2006-11-01), pages 658A, XP008088583, ISSN: 0006-4971 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008016660A2 (en) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006081431A3 (en) | Compounds for treating inflammatory and demyelinating diseases | |
WO2006113942A3 (en) | Method of inhibiting cathepsin activity | |
WO2008075068A3 (en) | Acylaminopyrazoles as fgfr inhibitors | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
WO2009051670A3 (en) | Oxylipin compounds for the treatment of ophthalmic conditions | |
WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
TW200728307A (en) | Novel spirochromanone derivatives | |
WO2007059230A3 (en) | Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors | |
WO2008048867A3 (en) | Bicyclic heteroaromatic compounds | |
TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
MX2009004096A (en) | Talarazole metabolites. | |
TN2012000248A1 (en) | Novel spiropiperidine compounds | |
MX346186B (en) | Protein kinase inhibitors. | |
WO2008048589A3 (en) | Compounds and methods for treatment of hcv | |
WO2008019395A3 (en) | Compounds for improving learning and memory | |
WO2008064866A8 (en) | Treatment for multiple myeloma | |
MX2009003081A (en) | Pyrrole derivatives useful for the treatment of cytokine-mediated diseases. | |
WO2010066629A3 (en) | Novel azaindoles | |
WO2006127379A3 (en) | Par2-modulating compounds and their use | |
WO2009098458A3 (en) | Difluorobiphenylamide derivatives for the treatment of ocular hypertension | |
WO2008009210A8 (en) | Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases | |
NZ597866A (en) | Therapeutic lactams | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
WO2007112913A3 (en) | Benzimidazole derivatives | |
WO2007092436A3 (en) | Compounds for treating inflammatory disorders, demyelinating disorders and cancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07836426 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07836426 Country of ref document: EP Kind code of ref document: A2 |